Common Stock, Value, Issued in USD of CERO THERAPEUTICS HOLDINGS, INC. from Q4 2022 to Q4 2023

Taxonomy & unit: us-gaap: USD
Description: Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary: CERO THERAPEUTICS HOLDINGS, INC. quarterly Common Stock, Value, Issued history and change rate from Q4 2022 to Q4 2023.
CERO THERAPEUTICS HOLDINGS, INC. Common Stock, Value, Issued for the quarter ending 31 Dec 2023 was $1, a 99% decline year-over-year.
Source SEC data: View on sec.gov

Common Stock, Value, Issued, Quarterly (USD)

Common Stock, Value, Issued, YoY Quarterly Change (%)

CERO THERAPEUTICS HOLDINGS, INC. Quarterly Common Stock, Value, Issued (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2023	$1	-$87	-99%	31 Dec 2023	10-K	15 Apr 2025	2024	FY
Q2 2023	$88			30 Jun 2023	10-Q	14 Aug 2023	2023	Q2
Q4 2022	$88			31 Dec 2022	10-Q	14 Aug 2023	2023	Q2

* An asterisk sign (*) next to the value indicates that the value is likely invalid.